Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04372485 · ClinicalTrials.gov registry record · NA
Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
A NA study of Sexually Transmitted Diseases, sponsored by Children's National Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 270
- Enrollment target
- 1
- Study location
NCT04372485: Recruiting NA study of Sexually Transmitted Diseases, sponsored by Children's National Research Institute.
NCT04372485 is a NA study of Sexually Transmitted Diseases that is actively recruiting participants, run by Children's National Research Institute. The registered enrollment target is 270 participants, below the 1,243-participant average among 35 other Sexually Transmitted Diseases trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04372485, a NA study of Sexually Transmitted Diseases, is actively recruiting participants, sponsored by Children's National Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 270 participants
- Enrollment target
- 1
- Study location
Study Summary
We will conduct a randomized trial to compare differences in sexually transmitted infection (STI) treatment adherence between patients receiving text messages versus those receiving usual care (e.g. no text messages). We hypothesize that STI treatment adherence will be 20% higher among patients randomized to receipt of two-way text messaging services.
Primary Outcome
Proportion of study participants who complete their medication as prescribed by self-report
Conditions Studied
Interventions
- BEHAVIORAL mHealth Intervention
Study Locations (1)
District of Columbia
- Children's National Hospital - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2024-06-03 |
| Est. Completion | 2027-06 |
| Phase | NA |
What NCT04372485 shows while recruiting
NCT04372485 is an interventional study that assigns participants to a tested intervention. The registered 270 participants enrollment target is mid-sized for trials with a published cap, below the 1,243-participant average among 35 other Sexually Transmitted Diseases trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Sexually Transmitted Diseases appearing as the primary indexed condition, and to 1 intervention - of which mHealth Intervention is the first listed.
NCT04372485 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT04372485 about?
NCT04372485 is a clinical study titled "Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents". We will conduct a randomized trial to compare differences in sexually transmitted infection (STI) treatment adherence between patients receiving text messages versus those receiving usual care (e.g. no text messages). We hypothesize that STI treatment adherence will be 20% higher among patients rand...
What is the current status of trial NCT04372485?
This trial is currently recruiting. It is a NA study. The enrollment target is 270 participants. The study started on 2024-06-03. Estimated completion is 2027-06.
What conditions does trial NCT04372485 study?
This clinical trial studies the following conditions: Sexually Transmitted Diseases.
What interventions are being tested in trial NCT04372485?
The interventions under investigation include: mHealth Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04372485?
This trial is sponsored by Children's National Research Institute, which has 92 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04372485 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sexually Transmitted Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04372485's enrollment target sits among peer trials
270 23rd of 35 higher than 13 of 35 other Sexually Transmitted Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sexually Transmitted Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Rigorous Evaluation of Yes and Know, a Fully Virtual Sexual Health and Well-Being Intervention for Youth
RECRUITING · NA
-
Evaluation of Parent Toolkit 2.0 (Morehouse Family Health Study)
RECRUITING · NA
-
Health Information Technology to Reduce Disparities in Adolescent Health Outcomes: A Pragmatic Trial
RECRUITING · NA
-
Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention
RECRUITING · NA
-
Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years
RECRUITING · NA
-
Evaluation of an Adolescent Pregnancy Prevention Program; Relationship Smarts+ With Lessons From Mind Matters
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00801489 · 270 participants · Phase 2
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- NCT04528446 · 270 participants
The Impact of Glomerular Disorders on Bone Quality and Strength
- NCT05215327 · 270 participants · Phase 2
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
- NCT05362292 · 270 participants · Phase 4
TReating Incontinence for Underlying Mental and Physical Health
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI